X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1962) 1962
Publication (117) 117
Book Chapter (22) 22
Book Review (9) 9
Dissertation (8) 8
Book / eBook (2) 2
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1337) 1337
female (1308) 1308
ovarian neoplasms - pathology (924) 924
adult (742) 742
index medicus (715) 715
middle aged (695) 695
obstetrics & gynecology (676) 676
oncology (656) 656
ovarian cancer (535) 535
aged (513) 513
cancer (512) 512
pathology (508) 508
carcinoma (418) 418
borderline tumors (412) 412
ovary (362) 362
neoplasm staging (358) 358
prognosis (352) 352
ovarian neoplasms - surgery (343) 343
tumors (342) 342
borderline (315) 315
retrospective studies (284) 284
surgery (281) 281
ovarian neoplasms - genetics (264) 264
aged, 80 and over (253) 253
adolescent (252) 252
immunohistochemistry (233) 233
borderline ovarian tumor (232) 232
ovarian neoplasms - diagnosis (219) 219
diagnosis (218) 218
recurrence (196) 196
young adult (195) 195
cystadenocarcinoma, serous - pathology (192) 192
women (183) 183
fertility (167) 167
management (156) 156
adenocarcinoma, mucinous - pathology (155) 155
survival (154) 154
borderline ovarian tumors (152) 152
borderline tumor (150) 150
expression (150) 150
epithelial tumors (145) 145
ovarian neoplasms - metabolism (144) 144
neoplasm invasiveness (141) 141
ovarian neoplasms - mortality (140) 140
diagnosis, differential (137) 137
mutation (130) 130
neoplasms (130) 130
obstetrics and gynecology (127) 127
pregnancy (127) 127
serous borderline tumors (122) 122
benign (121) 121
follow-up studies (119) 119
malignancy (118) 118
carcinomas (115) 115
risk factors (114) 114
peritoneal implants (112) 112
treatment outcome (110) 110
analysis (109) 109
laparoscopy (109) 109
ovarian neoplasms - therapy (106) 106
chemotherapy (103) 103
clinicopathological analysis (103) 103
research (103) 103
survival rate (103) 103
ovarian neoplasms - epidemiology (100) 100
borderline malignancy (99) 99
serous borderline tumor (99) 99
mucinous tumors (97) 97
behavior (96) 96
ovarian carcinoma (96) 96
mutations (90) 90
serous tumors (90) 90
carcinoma - pathology (89) 89
medicine & public health (89) 89
ovarian tumors (89) 89
ovarian neoplasms - classification (88) 88
neoplasms, glandular and epithelial - pathology (87) 87
reproductive biology (84) 84
care and treatment (83) 83
features (83) 83
follow-up (83) 83
low-grade (83) 83
neoplasm recurrence, local - pathology (83) 83
ovarian neoplasms (83) 83
conservative surgery (80) 80
cystadenoma, serous - pathology (79) 79
ovariectomy (79) 79
health aspects (77) 77
hematology, oncology and palliative medicine (77) 77
metastasis (77) 77
origin (77) 77
ovary - pathology (77) 77
endocrine system diseases (76) 76
intestinal-type (76) 76
ovarian neoplasms - diagnostic imaging (75) 75
endometriosis (74) 74
conservative treatment (73) 73
radiology, nuclear medicine & medical imaging (73) 73
cystadenocarcinoma, serous - genetics (72) 72
low malignant potential (72) 72
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1786) 1786
French (73) 73
Korean (52) 52
German (37) 37
Spanish (15) 15
Japanese (11) 11
Russian (8) 8
Turkish (8) 8
Portuguese (4) 4
Chinese (3) 3
Czech (3) 3
Polish (3) 3
Italian (2) 2
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Journal of Pathology, ISSN 0022-3417, 12/2013, Volume 231, Issue 4, pp. 449 - 456
BRAF and KRAS mutations in ovarian serous borderline tumours (OSBTs) and ovarian low‐grade serous carcinomas (LGSCs) have been previously described. However,... 
mutation | deep sequencing | ovarian low‐grade serous carcinoma | KRAS | BRAF | serous borderline tumour | COLD‐PCR | COLD-PCR | ovarian low-grade serous carcinoma | SURVIVAL | NEOPLASMS | IMPLANTS | PATHOLOGY | PATHOGENESIS | CANCER GENOMICS | ONCOLOGY | RAS MUTATIONS | PROTEIN MUTATIONS | EXPRESSION | ras Proteins - genetics | Proto-Oncogene Proteins p21(ras) | Prognosis | Humans | Middle Aged | Ovarian Neoplasms - pathology | Cystadenocarcinoma, Serous - genetics | Cystadenocarcinoma, Serous - pathology | DNA Mutational Analysis - methods | Neoplasm Recurrence, Local - pathology | Ovarian Neoplasms - genetics | Young Adult | Neoplasm Grading | Adult | Female | Cell Death - drug effects | Tumor Cells, Cultured | High-Throughput Nucleotide Sequencing - methods | MAP Kinase Kinase Kinases - antagonists & inhibitors | Neoplasm Proteins - genetics | Kaplan-Meier Estimate | Proto-Oncogene Proteins - genetics | Proto-Oncogene Proteins B-raf - genetics | Benzimidazoles - pharmacology | Neoplasm Recurrence, Local - genetics | Aged | Protein Kinase Inhibitors - pharmacology | DNA, Neoplasm - genetics | Mutation | Cystadenoma, Serous - genetics | Cystadenoma, Serous - pathology | Proteins | Relapse | Carcinoma | Gene mutations | Genomics | Analysis | Denaturation | Cancer | Diseases | KRAS mutation | Ovarian low-grade serous carcinoma | Serous borderline tumor | Deep sequencing | KRAS G12V | BRAF mutation | Full COLD-PCR
Journal Article
Journal Article
Cancer, ISSN 0008-543X, 03/2004, Volume 100, Issue 5, pp. 1045 - 1052
Journal Article
Journal Article
Journal Article